Skip to content

Startup & venture capital news

nPhase raises USD 30m Series D

Viking Global Investors backs clinical data platform expansion

By /

LinkedInX
nPhase: nPhase raises USD 30m Series D

nPhase announced a USD 30 million Series D on 2 November 2026, led by Viking Global Investors. The financing is the clinical technology company's first equity raise since 2017. nPhase connects trial and real world data through a governed platform for pharmaceutical sponsors and research organisations. Its software combines data management and statistical computing from study setup through regulatory submission. Chief executive Scott Climes said the capital will scale the enterprise business, expand agentic AI workflows and support international growth. The company did not disclose other investors or a valuation. The amount represents current equity proceeds rather than cumulative funding or a debt facility.

Keep reading

More Funding

All stories